1189548-17-1

Basic information

• Product Name: N-[(1S)-1-{[4-(4-cyanophenoxy)piperidin-1-yl]carbonyl}propyl]-3-hydroxyquinoxaline-2-carboxamide
• Synonyms: N-[(1S)-1-{[4-(4-cyanophenoxy)piperidin-1-yl]carbonyl}propyl]-3-hydroxyquinoxaline-2-carboxamide
• CAS NO: 1189548-17-1
• Molecular Weight: 459.505
• Mol File: 1189548-17-1.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: N-[(1S)-1-{[4-(4-cyanophenoxy)piperidin-1-yl]carbonyl}propyl]-3-hydroxyquinoxaline-2-carboxamide(CAS DataBase Reference)
• NIST Chemistry Reference: N-[(1S)-1-{[4-(4-cyanophenoxy)piperidin-1-yl]carbonyl}propyl]-3-hydroxyquinoxaline-2-carboxamide(1189548-17-1)
• EPA Substance Registry System: N-[(1S)-1-{[4-(4-cyanophenoxy)piperidin-1-yl]carbonyl}propyl]-3-hydroxyquinoxaline-2-carboxamide(1189548-17-1)

Safety Data

• Hazardous Substances Data: 1189548-17-1(Hazardous Substances Data)

Upstream product

• 1189549-55-0 4-({1-[(2S)-2-aminobutanoyl]piperidin-4-yl}oxy)benzonitrile hydrochloride 
• 1204-75-7 3-hydroxyquinoxaline-2-carboxylic acid 

Relevant articles and documents

HYDROXYQUINOXALINECARBOXAMIDE DERIVATIVE

The present invention provides a novel hydroxyquinoxaline carboxamide derivative that is useful for preventing and/or treating blood coagulation disorders. A compound represented by formula (i), or a pharmacologically acceptable salt thereof: wherein, each of R1 and R2 independently represents a group such as a hydrogen atom or a halogen atom; R3 represents a group such as a hydrogen atom; each of R4 and R5 independently represents a group such as a hydrogen atom, a halogen atom or a C1-4 alkyl group; each of R6 and R7 independently represents a hydrogen atom or a C1-4 alkyl group; X represents a group such as a C3-10 cycloalkyl group, C6-10 aryl group or a 5- to 10-membered heterocyclic group, which may be substituted with substituent(s) selected from substituent group α; Y represents a group such as -CO-, -O- or -NRa-, and Ra represents a group such as a hydrogen atom or a C1-4 alkyl group.